Melanoma Cell Resistance to Vemurafenib Modifies Inter-Cellular Communication Signals

The therapeutic success of BRAF inhibitors (BRAFi) and MEK inhibitors (MEKi) in BRAF-mutant melanoma is limited by the emergence of drug resistance, and several lines of evidence suggest that changes in the tumor microenvironment can play a pivotal role in acquired resistance. The present study focu...

Descripción completa

Detalles Bibliográficos
Autores principales: Tabolacci, Claudio, Cordella, Martina, Mariotti, Sabrina, Rossi, Stefania, Senatore, Cinzia, Lintas, Carla, Levati, Lauretta, D’Arcangelo, Daniela, Facchiano, Antonio, D’Atri, Stefania, Nisini, Roberto, Facchiano, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830125/
https://www.ncbi.nlm.nih.gov/pubmed/33467521
http://dx.doi.org/10.3390/biomedicines9010079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830125/
https://www.ncbi.nlm.nih.gov/pubmed/33467521
http://dx.doi.org/10.3390/biomedicines9010079

Ejemplares similares